Abstract:RATIONALE & OBJECTIVE: <AbstractText Label="RATIONALE & OBJECTIVE" NlmCategory="OBJECTIVE">Low serum magnesium level has been shown to be associated with increased mortality, but its role as a predictor of cardiovascular disease is unclear. This study evaluates the association between serum magnesium level and cardiovascular events and all-cause mortality in a large cohort of individuals with chronic kidney disease (CKD).</AbstractText>STUDY DESIGN: <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Prospective cohort study.</AbstractText>SETTING & PARTICIPANTS: <AbstractText Label="SETTING & PARTICIPANTS" NlmCategory="METHODS">3,867 participants with CKD, enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study.</AbstractText>EXPOSURES: <AbstractText Label="EXPOSURES" NlmCategory="METHODS">Serum magnesium measured at study baseline.</AbstractText>OUTCOMES: <AbstractText Label="OUTCOMES" NlmCategory="RESULTS">Composite cardiovascular events (myocardial infarction, cerebrovascular accident, heart failure, and peripheral arterial disease) and all-cause mortality.</AbstractText>ANALYTICAL APPROACH: <AbstractText Label="ANALYTICAL APPROACH" NlmCategory="METHODS">Cox proportional hazards models adjusted for demographic, clinical, and laboratory characteristics.</AbstractText>RESULTS: <AbstractText Label="RESULTS" NlmCategory="RESULTS">During the 14.6 (4.4) years (standard deviation) of follow-up, 1,384 participants died (36/1,000 person-years), and 1,227 (40/1,000 person-years) had a composite cardiovascular event. There was a nonlinear association between serum magnesium level and all-cause mortality. Low and high magnesium levels were associated with greater rates of all-cause mortality after adjusting for demographics, comorbid conditions, medications including diuretics, estimated glomerular filtration rate, and proteinuria (<i>P</i> < 0.001). No significant associations were observed between serum magnesium levels and the composite cardiovascular events. Low serum magnesium level was associated with incident atrial fibrillation (HR, 1.36; 95% CI, 1.01-1.82; <i>P</i> = 0.04).</AbstractText>LIMITATIONS: <AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Single measurement of serum magnesium.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this large CKD cohort, serum magnesium level < 1.9 mg/dL and >2.1 mg/dL was associated with increased risk for all-cause mortality. Low magnesium level was associated with incident atrial fibrillation but not with composite cardiovascular disease events. Further studies are needed to determine the optimal range of serum magnesium in CKD to prevent adverse clinical outcomes.</AbstractText>

Compound Hub: efficiency gains through innovative sample management processes.

Association between serum magnesium trajectory and in-hospital mortality in hospitalized patients with sepsis: an analysis of the MIMIC-IV database

Association of magnesium sulfate use with mortality in critically ill patients with sepsis: a retrospective propensity score-matched cohort study

Effects of serum magnesium level on mortality in maintenance hemodialysis patients

Association between short-term changes in serum magnesium and in-hospital mortality following acute myocardial infarction: a cohort study based on the MIMIC database

A time-integrating environmental radon daughter monitor.

High Serum Iron level is Associated with Increased Mortality in Patients with Sepsis

Admission Low Magnesium Level Is Associated with In-Hospital Mortality in Acute Ischemic Stroke Patients

Association of Serum Magnesium on Mortality in Patients Admitted to the Intensive Cardiac Care Unit

Serum magnesium, mortality and disease progression in chronic kidney disease

Association Between Predialysis Hypermagnesaemia and Morbidity of Uraemic Restless Legs Syndrome in Maintenance Haemodialysis Patients: a Retrospective Observational Study in Zhejiang, China

Serum calcium-magnesium ratio at admission predicts adverse outcomes in patients with acute coronary syndrome

The U-shaped association between serum osmolality and 28-day mortality in patients with sepsis: a retrospective cohort study

Calcium supplementation prolongs the time of hospitalization and has a double effect on mortality in septic patients: A retrospective study from MIMIC-III

Association between magnesium, erythropoietin resistance and mortality: the Japanese Dialysis Outcomes and Practice Patterns Study (J-DOPPS)

Serum Magnesium and Cardiovascular Outcomes and Mortality in CKD: The Chronic Renal Insufficiency Cohort (CRIC)

Low Serum Magnesium is Associated with Poor Functional Outcome in Acute Ischemic Stroke or Transient Ischemic Attack Patients.

U-shaped association between serum triglyceride levels and mortality among septic patients: An analysis based on the MIMIC-IV database

Magnesium protects against sepsis by blocking gasdermin D N-terminal-induced pyroptosis

Inverse Correlation Between Plasma Sphingosine-1-Phosphate and Ceramide Concentrations in Septic Patients and Their Utility in Predicting Mortality.

Association of Admission Serum Calcium Levels and In-Hospital Mortality in Patients with Acute ST-elevated Myocardial Infarction: an Eight-Year, Single-Center Study in China.